WHO ICTRP trial
Optimization of transplantation of cell suspension in the treatment of vitiligo
IRCT20200127046282N2 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20200127046282N2 |
|---|---|
| Public title | Optimization of transplantation of cell suspension in the treatment of vitiligo |
| Scientific title | Optimization of autologous melanocyte and keratinocyte cells suspention transplantation for vitiligo treatment |
| Primary sponsor | Tehran University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 2 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Vitiligo. disorders of pigmentation |
| Interventions | Intervention group: The pigment-free area is first removed and then the processed cell suspension is transferred to the desired area and covered with a suitable dressing.. |
| Registration date | May 28, 2021 |
| Target size | 15 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: